LIPID METABOLISM DEFICIENCY: CLINICAL EXOME PANEL (Sec. & CNVs) – 63 genes

LabGenetics
Caja de LIPID METABOLISM DEFICIENCY: CLINICAL EXOME PANEL (Sec. & CNVs) – 63 genes

Delivery time

3-4 weeks

Sample

Blood

850,00€
Caja de LIPID METABOLISM DEFICIENCY: CLINICAL EXOME PANEL (Sec. & CNVs) – 63 genes

The Lipid Metabolism Deficiency Panel analyzes 63 genes involved in inherited disorders affecting the synthesis, transport, and degradation of fatty acids, triglycerides, and other essential lipids. These disorders can manifest as hypoketotic hypoglycemia, hepatomegaly, myopathy, cardiomyopathy, fasting intolerance, or progressive neurological involvement. The panel covers a broad spectrum of metabolic diseases, including mitochondrial β-oxidation defects (ACADM, ACADVL, HADHA, HADHB, CPT1A, CPT2, SLC25A20), fatty acid synthesis or elongation disorders (ACACA, ACACB, ELOVL4, FASN), ketone body metabolism disorders (HMGCL, HMGCS2, OXCT1), and lipid transport and storage defects (SLC22A5, LIPE, PNPLA2, FABP1). Using next-generation sequencing (NGS) with analysis of SNVs, indels, and CNVs, this study detects pathogenic variants responsible for clinical conditions of muscular, hepatic, or systemic dysfunction related to lipid metabolism. Some of the genes included in this panel are: ACADM, ACADVL, CPT1A, CPT2, HADHA, HADHB, SLC22A5, SLC25A20, HMGCL, HMGCS2, and LIPE, among others. For a complete list of genes, please contact Genotica.

Other tests

Preventive health test - AboutMe EXOME

Preventive health test - AboutMe EXOME

545,00€

NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical

NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical

600,00€

Custom sequencing panels (1 to 15 genes)

Custom sequencing panels (1 to 15 genes)

660,00€